The unified social credit code/registration number of R&D (Shanghai) Co., Ltd. is 9131532 9555538n, and the enterprise is in the opening state.
The business scope of R&D (Shanghai) Co., Ltd. is: research and development of biomedicine, chemical drugs and medical devices (except the development and application of human stem cells and gene diagnosis and treatment technology), transfer its own technological achievements, and provide relevant technical consultation and technical support services. Projects that are subject to approval according to law can only carry out business activities after being approved by relevant departments. In Shanghai, the total registered capital of companies with similar business scope is 869.32 million yuan, and the main capital is concentrated in1000-50 million and1000 million enterprises, with * * 156. In the province, the registered capital of enterprises is good at present.
See more information about Xeclone Pharmaceutical R&D (Shanghai) Co., Ltd. through Baidu Enterprise Credit.